9989
vs
N
Nikkei 225
9989
Over the past 12 months, Sundrug Co Ltd has underperformed Nikkei 225, delivering a return of +10% compared to the Nikkei 225's +29% growth.
Stocks Performance
9989 vs Nikkei 225
Performance Gap
9989 vs Nikkei 225
Performance By Year
9989 vs Nikkei 225
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sundrug Co Ltd
Glance View
In the bustling landscape of Japanese retail, Sundrug Co., Ltd. emerges as a leader with its distinct approach to health and beauty. Founded in 1965, the company has grown from a single store to a robust network of over a thousand outlets, strategically located across Japan. This extensive expansion is driven by Sundrug’s commitment to offering an expansive range of products, from pharmaceuticals and cosmetics to everyday household goods. By positioning themselves as a one-stop shop for daily essentials and health-related products, they have captured a significant share of the market. Their success is underpinned by thoughtful site selection, prioritizing convenience and accessibility, which attracts a steady stream of customers. Sundrug's business model thrives on a combination of competitive pricing and exceptional customer service, which have become their hallmark. They operate on a high-volume, low-margin strategy, allowing them to keep their prices attractive and foster customer loyalty. In addition to physical stores, Sundrug has embraced e-commerce, recognizing the shift in consumer behavior towards online shopping. Through an omnichannel approach, the company has integrated its physical and digital platforms, enhancing the customer experience by offering the flexibility of in-store pickups and home deliveries. This strategic blend of traditional and digital retail, coupled with efficient supply chain management, is how Sundrug effectively generates its revenue and sustains its market position.
